Considerations for the selection of disease-modifying treatments in SMA: A case-based discussion

Leading experts in spinal muscular atrophy (SMA) explore factors influencing treatment decision-making with approved SMA therapies using three patient case studies.


Watch here: https://touchneurology.com/cme/selecting-disease-modifying-treatments-in-sma/

This activity is funded by an independent medical education grant from Biogen and Novartis Gene Therapies. This activity is jointly provided by USF Health and touchIME.